Picture of Carasent AB (publ) logo

CARA Carasent AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareAdventurousSmall CapFalling Star

Brief: Carasent Cuts FY Guidance

July 8 (Reuters) - Carasent AB (publ) CARAS.ST:

ANNOUNCED ON MONDAY REVISED 2025 TARGETS

SEES FY REVENUES OF AROUND SEK 345-350 MILLION VS EARLIER VIEW ABOUT 350 MILLION

SEES FY EBITDA OF AROUND SEK 75 MILLION (EARLIER VIEW: 82-87 MILLION)

SEES FY EBITDAC OF AROUND SEK 35 MILLION (EARLIER VIEW 44-49 MILLION

SEES Q2 REVENUES OF SEK 83 MILLION

SEES Q2 EBITDA OF SEK 12 MILLION

REVENUES IN H1 ARE SLIGHTLY LOWER THAN ANTICIPATED

H1 PROFITABILITY HIT BY EXTRA COSTS COMPARED TO PREVIOUSLY COMMUNICATED TARGETS

ANNOUNCED NEW MEDIUM-TERM FINANCIAL TARGETS

AVERAGE ANNUAL ORGANIC REVENUE GROWTH OF 15% FROM 2026-2028

EBITDA MARGIN OF 35% BY 2028

CAPEX MID TO HIGH SINGLE DIGIT % OF REVENUE

 Source text for Workspace: nMFN94h0X0
 Further company coverage: CARAS.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Carasent AB (publ)

See all news